As of 2025-03-22, the Relative Valuation of Altimmune Inc (ALT) is (33.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of Altimmune Inc based on Relative Valuation is -672.0%.
The range of the Relative Valuation is (26.34) - (38.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.3x - 36.5x | 28.9x |
| Forward P/E multiples | 19.1x - 30.8x | 25.0x |
| Fair Price | (26.34) - (38.02) | (33.24) |
| Upside | -553.4% - -754.4% | -672.0% |
| Date | P/E |
| 2025-03-17 | -4.84 |
| 2025-03-14 | -4.80 |
| 2025-03-13 | -4.21 |
| 2025-03-12 | -4.50 |
| 2025-03-11 | -4.26 |
| 2025-03-10 | -4.42 |
| 2025-03-07 | -4.51 |
| 2025-03-06 | -4.53 |
| 2025-03-05 | -4.63 |
| 2025-03-04 | -4.83 |
| 2025-03-03 | -4.85 |
| 2025-02-28 | -5.39 |
| 2025-02-27 | -5.20 |
| 2025-02-26 | -4.81 |
| 2025-02-25 | -4.79 |
| 2025-02-24 | -4.95 |
| 2025-02-21 | -5.21 |
| 2025-02-20 | -5.37 |
| 2025-02-19 | -5.49 |
| 2025-02-18 | -5.25 |
| 2025-02-14 | -5.16 |
| 2025-02-13 | -5.05 |
| 2025-02-12 | -5.04 |
| 2025-02-11 | -5.10 |
| 2025-02-10 | -5.35 |
| 2025-02-07 | -5.40 |
| 2025-02-06 | -5.60 |
| 2025-02-05 | -5.66 |
| 2025-02-04 | -5.38 |
| 2025-02-03 | -5.22 |
| 2025-01-31 | -5.38 |
| 2025-01-30 | -5.67 |
| 2025-01-29 | -5.63 |
| 2025-01-28 | -5.61 |
| 2025-01-27 | -5.67 |
| 2025-01-24 | -5.65 |
| 2025-01-23 | -5.72 |
| 2025-01-22 | -5.62 |
| 2025-01-21 | -5.53 |
| 2025-01-17 | -5.56 |
| 2025-01-16 | -5.44 |
| 2025-01-15 | -5.33 |
| 2025-01-14 | -5.05 |
| 2025-01-13 | -5.49 |
| 2025-01-10 | -5.57 |
| 2025-01-08 | -6.04 |
| 2025-01-07 | -5.92 |
| 2025-01-06 | -5.87 |
| 2025-01-03 | -5.88 |
| 2025-01-02 | -5.76 |